company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2009.0,Q4,2009-10-01,2009-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,964000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2009.0,Q4,2009-10-01,2009-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,964000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2009.0,Q4,2009-10-01,2009-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,78000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2009.0,Q4,2009-10-01,2009-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-4064000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2009.0,Q4,2009-10-01,2009-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-371000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2009.0,Q4,2009-10-01,2009-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-3393000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2009.0,Q4,2009-10-01,2009-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-3393000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2009.0,Q4,2009-10-01,2009-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-8000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2009.0,Q4,2009-10-01,2009-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-8000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2009.0,Q4,2009-10-01,2009-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-8000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2009.0,Q4,2009-10-01,2009-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-380000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2009.0,Q4,2009-10-01,2009-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,45188000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2009.0,Q4,2009-10-01,2009-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,352000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2009.0,Q4,2009-10-01,2009-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,45160000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2009.0,Q4,2009-10-01,2009-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,45160000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2009.0,Q4,2009-10-01,2009-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,41759000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2010.0,Q3,2010-07-01,2010-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-12205000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-12205000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,37000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,4736000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1625000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-5807000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2010.0,Q3,2010-07-01,2010-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-5807000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-50000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2010.0,Q3,2010-07-01,2010-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-50000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2010.0,Q3,2010-07-01,2010-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-50000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,0.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,0.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,0.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2010.0,Q3,2010-07-01,2010-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-1334000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2010.0,Q3,2010-07-01,2010-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-7191000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2010.0,Q4,2010-10-01,2010-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-11851000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-11851000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,35000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,6665000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-632000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-5783000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2010.0,Q4,2010-10-01,2010-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-5783000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-58000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2010.0,Q4,2010-10-01,2010-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-58000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2010.0,Q4,2010-10-01,2010-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-58000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-239000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-238000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2010.0,Q4,2010-10-01,2010-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-238000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2010.0,Q4,2010-10-01,2010-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-6079000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 16:06:59+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-39008000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 16:06:59+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-39008000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 16:06:59+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,37000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 16:06:59+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,29239000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 16:06:59+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1565000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 16:06:59+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-8167000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 16:06:59+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-8167000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 16:06:59+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-227000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 16:06:59+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-227000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 16:06:59+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-227000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 16:06:59+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,71285000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 16:06:59+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,910000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 16:06:59+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,72195000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 16:06:59+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,72039000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 16:06:59+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,63645000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 16:06:59+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,0.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 16:06:59+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,0.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2011.0,Q2,2011-04-01,2011-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-10724000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-10724000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,58000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-1503000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,6347000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-5822000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2011.0,Q2,2011-04-01,2011-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-5822000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-165000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2011.0,Q2,2011-04-01,2011-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-165000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2011.0,Q2,2011-04-01,2011-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-165000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,12232000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,12232000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2011.0,Q2,2011-04-01,2011-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,12232000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2011.0,Q2,2011-04-01,2011-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,6245000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2011.0,Q3,2011-07-01,2011-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-802000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-802000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,77000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-12802000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,2431000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-11096000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2011.0,Q3,2011-07-01,2011-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-11096000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-414000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2011.0,Q3,2011-07-01,2011-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-414000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2011.0,Q3,2011-07-01,2011-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-414000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,161000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,161000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2011.0,Q3,2011-07-01,2011-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,161000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2011.0,Q3,2011-07-01,2011-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-11349000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2011.0,Q4,2011-10-01,2011-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-13244000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-13244000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,96000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-2301000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1699000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-13750000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2011.0,Q4,2011-10-01,2011-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-13750000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-350000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2011.0,Q4,2011-10-01,2011-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-350000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2011.0,Q4,2011-10-01,2011-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-350000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,0.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,0.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,0.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2011.0,Q4,2011-10-01,2011-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-120000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2011.0,Q4,2011-10-01,2011-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-14220000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2012.0,Q3,2012-07-01,2012-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-17824000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-17824000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,201000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-2705000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,5621000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-14707000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-14707000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-375000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2012.0,Q3,2012-07-01,2012-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-375000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-375000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,0.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,0.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,24000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2012.0,Q3,2012-07-01,2012-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-15058000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2012.0,Q4,2012-10-01,2012-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-30225000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-30225000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,192000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,11526000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-2993000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-21500000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-21500000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-77000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2012.0,Q4,2012-10-01,2012-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-77000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-77000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,0.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,0.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-450000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2012.0,Q4,2012-10-01,2012-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-22027000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2014.0,Q3,2014-07-01,2014-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-6093000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-6093000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,122000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1148000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-5668000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-10491000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-10491000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-94000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2014.0,Q3,2014-07-01,2014-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-94000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-94000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,3706000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,3706000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,3706000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2014.0,Q3,2014-07-01,2014-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-6879000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-10401000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-10401000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,123000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1160000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-752000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-9870000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-9870000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-412000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,6963000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,6551000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,6551000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2014.0,Q4,2014-10-01,2014-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-3319000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:01:39+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-78231000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:01:39+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-78231000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:01:39+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,122000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:01:39+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,68378000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:01:39+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,14000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:01:39+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-9717000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:01:39+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-9717000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:01:39+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-17000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:01:39+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-17000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:01:39+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-17000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:01:39+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-246000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:01:39+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,94320000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:01:39+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,2541000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:01:39+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,96615000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:01:39+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,96615000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:01:39+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,86881000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:01:39+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,0.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:01:39+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,0.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2015.0,Q2,2015-04-01,2015-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-14211000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-14211000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,114000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3483000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1080000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-11694000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-11694000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-5000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2015.0,Q2,2015-04-01,2015-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-5000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-5000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-34000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,599000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,565000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,565000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2015.0,Q2,2015-04-01,2015-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-11134000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2015.0,Q3,2015-07-01,2015-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-18170000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-18170000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,59000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1477000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,61837000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,45203000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,45203000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-3000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2015.0,Q3,2015-07-01,2015-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-3000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-3000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-133000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,226000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,93000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,93000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2015.0,Q3,2015-07-01,2015-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,45293000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-9476000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-9476000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,62000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1944000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-16332000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-23802000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-23802000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-387000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2015.0,Q4,2015-10-01,2015-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-387000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-387000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-139000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1202000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1063000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1063000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2015.0,Q4,2015-10-01,2015-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-23126000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2016.0,Q1,2016-01-01,2016-03-31,2017-05-01 16:02:04+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-12019000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2016.0,Q1,2016-01-01,2016-03-31,2017-05-01 16:02:04+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-12019000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2016.0,Q1,2016-01-01,2016-03-31,2017-05-01 16:02:04+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,72000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2016.0,Q1,2016-01-01,2016-03-31,2017-05-01 16:02:04+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2096000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2016.0,Q1,2016-01-01,2016-03-31,2017-05-01 16:02:04+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-6228000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2016.0,Q1,2016-01-01,2016-03-31,2017-05-01 16:02:04+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-16079000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2016.0,Q1,2016-01-01,2016-03-31,2017-05-01 16:02:04+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-16079000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2016.0,Q1,2016-01-01,2016-03-31,2017-05-01 16:02:04+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-157000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2016.0,Q1,2016-01-01,2016-03-31,2017-05-01 16:02:04+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-157000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2016.0,Q1,2016-01-01,2016-03-31,2017-05-01 16:02:04+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-157000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2016.0,Q1,2016-01-01,2016-03-31,2017-05-01 16:02:04+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-2000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2016.0,Q1,2016-01-01,2016-03-31,2017-05-01 16:02:04+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,367000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2016.0,Q1,2016-01-01,2016-03-31,2017-05-01 16:02:04+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,365000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2016.0,Q1,2016-01-01,2016-03-31,2017-05-01 16:02:04+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,365000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2016.0,Q1,2016-01-01,2016-03-31,2017-05-01 16:02:04+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-15871000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2016.0,Q1,2016-01-01,2016-03-31,2017-05-01 16:02:04+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,0.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2016.0,Q1,2016-01-01,2016-03-31,2017-05-01 16:02:04+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,0.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2016.0,Q2,2016-04-01,2016-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-131200000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-131200000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,83000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,121111000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-5067000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-15073000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-15073000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-100000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2016.0,Q2,2016-04-01,2016-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-100000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-100000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-853000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,184000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-669000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-669000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2016.0,Q2,2016-04-01,2016-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-15842000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2016.0,Q3,2016-07-01,2016-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-10854000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-10854000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,72000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1889000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-5216000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-14109000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-14109000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-212000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2016.0,Q3,2016-07-01,2016-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-212000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-212000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2016.0,Q3,2016-07-01,2016-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-14321000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-11224000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-11224000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,63000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2503000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-4406000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-13064000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-13064000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-82000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2016.0,Q4,2016-10-01,2016-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-82000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-82000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-647000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,163000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-484000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-484000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2016.0,Q4,2016-10-01,2016-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-13630000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:01:58+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-15487000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:01:58+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-15487000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:01:58+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,79000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:01:58+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3584000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:01:58+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-2453000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:01:58+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-14277000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:01:58+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-14277000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:01:58+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-358000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:01:58+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-358000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:01:58+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-358000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:01:58+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,29000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:01:58+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,29000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:01:58+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,29000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:01:58+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-14606000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:01:58+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,0.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:01:58+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,0.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2017.0,Q2,2017-04-01,2017-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-12862000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-12862000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,88000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1992000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-4741000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-15523000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-15523000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-27000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2017.0,Q2,2017-04-01,2017-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-27000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-27000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-1042000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,47270000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,69000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,46297000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,46297000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2017.0,Q2,2017-04-01,2017-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,30747000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2017.0,Q3,2017-07-01,2017-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-12701000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-12701000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,92000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1881000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1985000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-12713000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-12713000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-76000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2017.0,Q3,2017-07-01,2017-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-76000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-76000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2017.0,Q3,2017-07-01,2017-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-12788000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-13273000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-13273000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,110000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2292000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1285000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-12156000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-12156000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-276000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2017.0,Q4,2017-10-01,2017-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-276000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-276000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-1017000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-11000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-1028000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-1028000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2017.0,Q4,2017-10-01,2017-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-13460000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:04:36+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-16020000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:04:36+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-16020000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:04:36+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,117000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:04:36+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3687000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:04:36+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-6685000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:04:36+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-18901000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:04:36+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-18957000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:04:36+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-150000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:04:36+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-150000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:04:36+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-150000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:04:36+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-731000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:04:36+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-731000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:04:36+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-731000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:04:36+00:00,netchangeincash,othernetchangesincash,Other Net Changes in Cash,+,debit,usd,-19838000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:04:36+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-39676000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2018.0,Q2,2018-04-01,2018-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-12031000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-12031000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,0.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1857000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,0.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-10174000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-10174000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-226000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2018.0,Q2,2018-04-01,2018-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-226000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-226000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-544000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,240000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-304000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-304000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,othernetchangesincash,Other Net Changes in Cash,+,debit,usd,19838000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2018.0,Q2,2018-04-01,2018-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,9134000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2018.0,Q3,2018-07-01,2018-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-12585000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-12585000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,0.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,4078000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,0.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-8507000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-8507000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-169000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2018.0,Q3,2018-07-01,2018-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-169000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-169000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2018.0,Q3,2018-07-01,2018-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-8676000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-12481000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-12481000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,163000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,526200.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-73000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-11864800.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-11819000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,86000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2018.0,Q4,2018-10-01,2018-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,86000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,86000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-5408000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-347000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,47101000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,41346000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,41346000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2018.0,Q4,2018-10-01,2018-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,29613000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:01:42+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-13434000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:01:42+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-13434000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:01:42+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,140000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:01:42+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,495000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:01:42+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,2567000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:01:42+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-10232000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:01:42+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-10232000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:01:42+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-10000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:01:42+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-10000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:01:42+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-10000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:01:42+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-10242000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2019.0,Q2,2019-04-01,2019-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-14620000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-14620000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,156000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2169000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,4208000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-8087000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-8087000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-67000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2019.0,Q2,2019-04-01,2019-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-67000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-67000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-370000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,600000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,230000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,230000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2019.0,Q2,2019-04-01,2019-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-7924000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2019.0,Q3,2019-07-01,2019-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-73996000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-73996000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,157000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,62237000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,675000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-10927000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-10927000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-107000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2019.0,Q3,2019-07-01,2019-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-107000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-107000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,2971000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,52919000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,55890000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,55890000.0
ZIOPHARM Oncology Inc,ZIOP,,0001107421,2019.0,Q3,2019-07-01,2019-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,44856000.0
